Navigation Links
Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction
Date:10/27/2010

TEMPE, Ariz., Oct. 27 /PRNewswire/ -- Intrinsic Bioprobes today announced that the United States Patents and Trademark Office has issued US Patent 7,816,095 covering novel blood protein biomarkers related to cardiovascular disease. This patent is first of a series of patent applications that cover specific human protein variants as biomarkers with clinical utility.

"The biomarkers were discovered using Intrinsic Bioprobes' unique Mass Spectrometric Immunoassay technologies," says Urban Kiernan, Ph.D., the Director of Biomarker Discovery at Intrinsic Bioprobes. These newly identified biomarkers are modified forms of specific circulating blood proteins that, when used in combination, yield exceptional clinical sensitivity and specificity in the determination of myocardial infarction. "We are very excited about these biomarkers because they clearly demonstrate the significance of protein microheterogeneity in human disease, which has been largely unexplored niche in human molecular biology," adds Kiernan.

Intrinsic Bioprobes Inc. (IBI), located in Tempe, AZ, performs unbiased discovery, verification and population studies on full-length proteins, and discovers and defines microheterogeneity in disease-associated biomarker proteins within healthy and disease populations. IBI's principal focus is the development and application of clinical and diagnostic assays and platforms for rapid and sensitive protein biomarker analysis for early detection and efficient treatment of critical human diseases. IBI's advanced technologies are patented and proprietary process platforms and approaches for proteomic and other research and clinical applications that generally leverage advanced mass spectrometry technology. These approaches include IBI's MASSAY(R) technology system, its Mass Spectrometric Immunoassay (MSIA(TM)) technology and its Bioreactive Probes (BRP(TM)). The Company has developed a deep and growing base of intellectual property in its field, consisting of 19 issued patents and numerous pending patent applications.

For more information about Intrinsic Bioprobes Inc., please visit http://www.intrinsicbio.com.Contact: Dobrin NedelkovIntrinsic Bioprobes Inc.Tel. (480) 804-1778E-mail: info@intrinsicbio.comThis press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Intrinsic Bioprobes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
2. Onyx Pharmaceuticals Announces Third Quarter 2010 Financial Results Teleconference and Webcast
3. Baxa Corporation Announces 2011 Course Schedule for its STAR Center® Training Facility
4. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
5. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
6. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
7. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
8. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
9. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
10. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
11. Roper Industries Announces Record Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... DIEGO , March 1, 2017  Aethlon ... European Patent Office has granted European Patent Number ... In recent years, exosomes have emerged ... a wide range of disease conditions, including cancer, ... (CTE).  This granted European Patent is an important ...
(Date:3/1/2017)... 1, 2017  Numotion, the nation,s leading provider of ... Tek RMD ("robotic mobilization device") by Matia Robotics in ... is a motorized standing movement device that offers the ... to complete everyday activities from a standing position. Unlike ... RMD unassisted. Numotion is the exclusive distributor of the ...
(Date:3/1/2017)... ... and Markets has announced the addition of the "Global Infertility ... The Global Infertility Therapy Partnering Terms and Agreements since 2010 ... into by the world,s leading healthcare companies. The report ... discovery or development stage whereby the licensee obtains a right or ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... 2017 , ... Today, True Vision Funding LLC (TVF), a ... a new division for the purchase of sports and music entertainment contracts, including ... Clinton Portis, former Washington Redskins running back and supporter for TVF echoed his ...
(Date:3/1/2017)... ... March 01, 2017 , ... After a long period of indulging in ... juice cleanses and workouts top the detox categories, there is a rare yet successful ... Kerry Gaynor Method’s Vital Lung Detox is an herbal-based formula designed to help cleanse ...
(Date:3/1/2017)... ... March 01, 2017 , ... Look for a new collection of edible ... Drift Roses. Star Roses and Plants is launching their new Bushel and Berry ... and Berry Collection makes growing fresh fruit simple with a variety of easy-to-grow, low-maintenance ...
(Date:3/1/2017)... ... March 01, 2017 , ... Breast Surgeon, Dr. Dennis Holmes of ... stage breast cancer and where it fits in the treatment paradigm at Susan G. ... .” The event brings together leading cancer and wellness experts to share the latest ...
(Date:3/1/2017)... ... March 01, 2017 , ... Granite Peaks ... cancer screening rates by supporting the 80% by 2018 initiative, led by the ... the National Colorectal Cancer Roundtable (an organization co-founded by ACS and CDC). , ...
Breaking Medicine News(10 mins):